Group A (n = 36) | Group B (n = 37) | Group C (n = 11) | p | |
---|---|---|---|---|
Pre-PTT (s) | 16.0 (14.2–17.9) | 17.6 (16.3–19.2) ** | 19.7 (17.4–24.0) ** | 0.003 |
Post-PTT (s) | 14.2 (13.6–14.8) | 14.4 (13.7–16.0) | 14.1 (13.5–15.5) | 0.37 |
Pre-APTT (s) | 40.8 (37.5–49.9) | 51.2 (43.5–109.5) ** | 85.2 (79.5–180.0) ** | 0.001 |
Post-APTT (s) | 36.1 (33.3–38.1) | 38.5 (32.3–45.4) | 35.3 (32.0–60.4) | 0.34 |
Transfusion (ml) | ||||
RBC | 1540 ± 420 | 2240 ± 1400* | 4620 ± 1820****, †††† | < 0.0001 |
FFP | 960 ± 600 | 1800 ± 1200*** | 4680 ± 2400****, ††† | < 0.0001 |
PC | 380 ± 180 | 480 ± 320** | 520 ± 180** | 0.001 |
30-day mortality, n (%) | 3 (8) | 5 (14) | 0 (0) | 0.39 |